Stay updated on Pembrolizumab Maintenance in sNSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Maintenance in sNSCLC Clinical Trial page.

Latest updates to the Pembrolizumab Maintenance in sNSCLC Clinical Trial page
- CheckyesterdayChange DetectedThe page revision label was updated from v3.4.3 to v3.5.0. This change does not affect study details or core page behavior.SummaryDifference0.1%

- Check8 days agoChange DetectedThe page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.1%

- Check15 days agoChange DetectedNo additions or deletions were detected; the page content appears unchanged.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedRevision: v3.4.2 was added; prior updates and notices, including Revision: v3.4.1 and a government funding/operating status notice, were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check44 days agoChange DetectedAdded a general site notice about potential delays due to government funding and updated the revision tag to v3.4.1, removing the previous v3.4.0 tag. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check51 days agoChange DetectedThe page now shows a glossary toggle and new QC metadata (Last Update Submitted that Met QC Criteria) and a new revision (Revision: v3.4.0), while older QC metadata (Last Update Submitted that met QC Criteria), No FEAR Act data, and the previous revision (v3.3.4) were removed.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab Maintenance in sNSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Maintenance in sNSCLC Clinical Trial page.